BizToc

[ad_1]

Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing legal battles with antitrust enforcers in the U.S. and Europe. San Diego-based Illumina said in a Sunday statement that it made its decision to divest Grail after a U.S. appeals…

#illumina #sandiego #ilumina #menlopark #grail #llumina #jacobthaysen